Nonproft brings researchers, pharma together to treat neglected diseases

SEATTLE – A Seattle-based nonprofit is coordinating partnerships between medical researchers and pharmaceutical companies to address diseases that are typically neglected by drug developers.

The U.S. Centers for Disease Control estimates 219 million people were infected with malaria in 2010. Another 100 million people are believed to be infected with dengue fever each year. Despite their prevalence, Jennifer Dent, president of BIO Ventures for Global Health (BVGH), said in the past major pharmaceutical companies rarely invested in these diseases because there is little money to be made on their treatments.

Click here for full story.

No news to display.

Catalyzing research for neglected tropical diseases

In this article, WIPO Magazine hears from WIPO Re:Search partners about why the initiative is creati...

Open innovation

European Biopharmaceutical Review features the WIPO Re:Search program in its Autumn 2012 issue. Read...

Drug repurposing

Chemical & Engineering News reports on the recent trend to find new uses for approved drugs and shel...